SameDayDoctor is helping to stop the spread of HIV by increasing access to its PrEP (pre-exposure prophylaxis) service.
Two big research studies on the use of PrEP (pre-exposure prophylaxis) for HIV prevention are now coming to an end and both have shown that the use of PrEP can make a tremendous impact on the risk of HIV transmission with a risk reduction of greater than 86%.
The PROUD study (that will be running until April 2016) is looking at whether a daily, continuous dose of Truvada can reduce the risk of HIV transmission for high risk individuals. The outcome so far has been overwhelming with a risk reduction of over 86%.
The Ipergay study looked at intermittent dosing (to reduce cost of drugs and adherence) and involves taking Truvada only “as and when required” (2-24 hours before intercourse with two further tablets 24 and 48 hours after intercourse) and has shown a similar impact on the prevention of HIV.
Unfortunately PrEP is not available on the NHS and currently can only be accessed via involvement in a trial, at 56 Dean Street clinic. There are unregulated oversees pharmacies selling medicine online but these are not licensed, and there is no opportunity for medical advice and important blood tests and follow up.
To access the SameDayDoctor PreP service please contact us or ring 020 7631 0090.